PHAT · Healthcare · $591M
$7.30-0.82%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“VOQUEZNA의 핵심 성장 지표인 '신규 처방 전환율'이 매우 인상적이에요.”
In the company's words · 2026 1분기 earnings call